• Study on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease

    Recruiting

    2 1
    Czechia France Germany Greece Hungary Italy +5
  • Study of Aficamten for Children with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland Italy Spain
  • Study on Ropivacaine for Managing Post-Operative Pain in Patients Undergoing Lumbar Arthrodesis Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Spain
  • Study of cobimetinib and atezolizumab combination therapy in children and adults with advanced or metastatic soft tissue sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Title: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy The Netherlands Spain
  • Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Germany Hungary Ireland Italy +5
  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Germany
  • Study on the Effectiveness and Safety of Fosmanogepix Compared to Caspofungin and Fluconazole for Adults with Candidemia or Invasive Candidiasis

    Recruiting

    3 1 1
    Austria Belgium Bulgaria France Germany Greece +2

powered by